Cooling inflation has raised signals of a slowdown in the interest rate hikes. According to most economists in a Reuters poll, the Federal Reserve will end its tightening cycle after 25-basis-point hikes in February and March. It will likely hold interest rates steady for at least the rest of the year.
Last year, the Federal Reserve launched a series of seven rate hikes, bringing the benchmark rate from near zero to a range of 4.25% to 4.5%. Despite that, inflation remains above the Fed’s 2% target, leaving a slim chance of rate cuts anytime soon. Fed Vice Chair Lael Brainard pressed on staying ‘sufficiently restrictive’ for some time to curb price growth.
In addition, Bank of America CEO Brian Moynihan expects a ‘mild’ recession is likely. Moreover, economists surveyed by Bloomberg see a 70% chance of a recession in 2023.
In such an environment, it would be wise to invest in shares of fundamentally strong businesses which have been flying under the radar and are well-positioned to weather an economic slowdown and yield big gains.
To that end, fundamentally sound stocks, Corcept Therapeutics Incorporated (CORT) and…
Continue reading at STOCKNEWS.com
